Streetbeat News

Partnerships

AMST

Amesite Inc (NASDAQ:AMST) has announced a partnership with Partners for Advancing Clinical Education (PACE) to deliver accredited continuing education for healthcare professionals using its AI-powered platform. This collaboration allows Amesite to jointly develop and deliver accredited continuing education programs in healthcare, leveraging accreditations from ACCME, ACPE, and ANCC. Following the announcement, AMST shares increased by 2.71% to $2.10.

Portfolio Pulse from Shivani Kumaresan

March 04, 2024 | 3:26 pm

GOOG

GOOGL

META

MSFT

Alphabet Inc (GOOG, GOOGL) faces market volatility due to AI product Gemini's issues and leadership scrutiny, despite a +52% growth last year. JPMorgan maintains an 'Overweight' rating with a $165 target, citing challenges in Gen AI, cost re-engineering, and potential for a dividend. Google aims to close the Gen AI gap with Microsoft (MSFT) and OpenAI, amidst online ad market shifts and comparisons with Meta Platforms (META). A dividend could attract a broader investor base, contingent on business performance improvements.

Portfolio Pulse from Surbhi Jain

March 04, 2024 | 3:21 pm

CCCC

C4 Therapeutics' stock is trading higher following the announcement of a strategic discovery collaboration with Merck KGaA targeting critical oncogenic proteins. The collaboration includes a $16 million upfront payment to C4 Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 3:01 pm

ACB

Aurora Cannabis Inc. (NASDAQ:ACB) and its subsidiary, MedReleaf Australia, have launched medical cannabis pastilles in Australia, expanding their product range. This new offering includes three types of pastilles aimed at providing patients with more options for medical cannabis consumption. The launch is part of Aurora's strategy to support the growth of Australia's medical cannabis market, where MedReleaf holds the number two position. The pastilles are available under the Aurora brand and will soon include more options under the IndiMed brand.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 2:43 pm

Visa Inc. (NYSE:V) reported strong fiscal Q1 2024 results, with an 8% increase in payments volume and a 16% rise in cross-border volume. GAAP EPS rose by 20%, and non-GAAP EPS by 11%. The company expanded its acceptance locations by 17% and network tokens by 55%. Despite challenges like Regulation II impact and weather-related slowdowns, Visa remains optimistic about its future, bolstered by strategic partnerships and a commitment to innovation.

Portfolio Pulse from Tornado

March 04, 2024 | 2:43 pm

AMD

DELL

NVDA

Dell Technologies Inc (NYSE:DELL) reported fiscal 2024 Q4 results, surpassing analyst expectations with a nearly 20% share price increase, driven by strategic AI partnerships with Nvidia Corporation (NASDAQ:NVDA) and Advanced Micro Devices (NASDAQ:AMD). Despite an 11% YoY revenue drop to $25.04 billion, net income soared 89% YoY to $1.16 billion. Dell's AI-optimized servers and storage revenue showed significant growth. The company expects to return to growth in fiscal 2025, supported by AI investments and has increased its annual dividend by 20%.

Portfolio Pulse from Upwallstreet

March 04, 2024 | 2:37 pm

CSCO

DECK

DELL

SMCI

WHR

ZIONS

Super Micro Computer, Inc. (SMCI) is set to join the S&P 500 Index on March 18, alongside Deckers Outdoor Corp. (DECK), replacing Whirlpool Corporation (WHR) and Zions Bancorporation N.A. (ZIONS). Goldman Sachs initiated coverage on SMCI with a Neutral rating and a 12-month target price of $941. SMCI, a key player in AI infrastructure, has seen its shares surge nearly 1,000% in the past 14 months, outperforming Nvidia Corp. (NVDA). The company faces competition from DELL Technologies Inc. (DELL) and Cisco Systems Inc. (CSCO) as it expands into enterprise AI infrastructure.

Portfolio Pulse from Piero Cingari

March 04, 2024 | 2:34 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) announced its 'High-Energy Fast Charging Lithium Battery Graphite Anode Project' received approval from Guizhou Province's Department of Science and Technology. This project, part of the 'Industrialization of Advanced Scientific and Technological Achievements' plan, aims to enhance energy density, charging efficiency, and cycling performance of lithium batteries. The approval will provide additional funding and support, positioning EPOW as a leader in high-end battery graphite anode materials.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 2:28 pm

HURN

Huron (NASDAQ:HURN) has completed the acquisition of GG+A, a leading philanthropic management consulting firm. This move aims to enhance Huron's offerings in empowering educational, healthcare, arts, and nonprofit organizations through advanced philanthropic programs. The acquisition is expected to strengthen Huron's Education operating segment by integrating GG+A's consulting expertise with Huron's digital capabilities and client relationships.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 2:09 pm

NRXS

NeurAxis, Inc. (NYSE:NRXS), a medical technology company, announced that Blue Cross and Blue Shield of Kansas City (BCBSKC) will now cover its neuromodulation therapies, expanding its coverage to approximately 9.25 million individuals. This development is part of NeurAxis's commercial strategy to leverage clinical evidence for its IB-Stim technology to obtain payer coverage and drive market adoption.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 2:07 pm